TrialThe Journal of allergy and clinical immunology2016

Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.

Maddalena Migliavacca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.